Oligonucleotide aptamers for pathogen detection and infectious disease control.

Theranostics

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA.

Published: September 2021

During an epidemic or pandemic, the primary task is to rapidly develop precise diagnostic approaches and effective therapeutics. Oligonucleotide aptamer-based pathogen detection assays and control therapeutics are promising, as aptamers that specifically recognize and block pathogens can be quickly developed and produced through simple chemical synthesis. This work reviews common aptamer-based diagnostic techniques for communicable diseases and summarizes currently available aptamers that target various pathogens, including the SARS-CoV-2 virus. Moreover, this review discusses how oligonucleotide aptamers might be leveraged to control pathogen propagation and improve host immune system responses. This review offers a comprehensive data source to the further develop aptamer-based diagnostics and therapeutics specific for infectious diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419047PMC
http://dx.doi.org/10.7150/thno.61804DOI Listing

Publication Analysis

Top Keywords

oligonucleotide aptamers
8
pathogen detection
8
aptamers pathogen
4
detection infectious
4
infectious disease
4
disease control
4
control epidemic
4
epidemic pandemic
4
pandemic primary
4
primary task
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!